These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

905 related items for PubMed ID: 25623245

  • 1. Promoting remyelination in multiple sclerosis: current drugs and future prospects.
    Kremer D, Küry P, Dutta R.
    Mult Scler; 2015 Apr; 21(5):541-9. PubMed ID: 25623245
    [Abstract] [Full Text] [Related]

  • 2. [New therapeutic strategies for remyelination in multiple sclerosis].
    Kremer D, Hartung HP, Stangel M, Küry P.
    Nervenarzt; 2015 Aug; 86(8):934-46. PubMed ID: 26122637
    [Abstract] [Full Text] [Related]

  • 3. Current advancements in promoting remyelination in multiple sclerosis.
    Kremer D, Akkermann R, Küry P, Dutta R.
    Mult Scler; 2019 Jan; 25(1):7-14. PubMed ID: 30270725
    [Abstract] [Full Text] [Related]

  • 4. Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
    Zhang M, Ma Z, Qin H, Yao Z.
    Mol Neurobiol; 2016 Sep; 53(7):4406-16. PubMed ID: 26243185
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ, Hasselmann J, Augello C, Moore S, Tiwari-Woodruff SK.
    J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
    [Abstract] [Full Text] [Related]

  • 8. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA, Akirav EM.
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [Abstract] [Full Text] [Related]

  • 9. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO.
    Adv Exp Med Biol; 2017 May; 958():91-127. PubMed ID: 28093710
    [Abstract] [Full Text] [Related]

  • 10. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK, Blakemore WF.
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [Abstract] [Full Text] [Related]

  • 11. Thirteen compounds promoting oligodendrocyte progenitor cell differentiation and remyelination for treating multiple sclerosis: WO2010054307.
    Taupin P.
    Expert Opin Ther Pat; 2010 Dec; 20(12):1767-73. PubMed ID: 20954805
    [Abstract] [Full Text] [Related]

  • 12. Remyelination in multiple sclerosis: from concept to clinical trials.
    Kremer D, Göttle P, Flores-Rivera J, Hartung HP, Küry P.
    Curr Opin Neurol; 2019 Jun; 32(3):378-384. PubMed ID: 30865009
    [Abstract] [Full Text] [Related]

  • 13. Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis Progression.
    Zeydan B, Rodriguez M, Kantarci OH.
    Adv Exp Med Biol; 2017 Jun; 958():161-170. PubMed ID: 28093713
    [Abstract] [Full Text] [Related]

  • 14. Remyelination in multiple sclerosis: a new role for neurotrophins?
    Althaus HH.
    Prog Brain Res; 2004 Jun; 146():415-32. PubMed ID: 14699977
    [Abstract] [Full Text] [Related]

  • 15. Remyelination in multiple sclerosis: what do we know and where are we going?
    Williams A.
    Neurodegener Dis Manag; 2015 Jun; 5(1):49-59. PubMed ID: 25711454
    [Abstract] [Full Text] [Related]

  • 16. Remyelination in multiple sclerosis.
    Piaton G, Williams A, Seilhean D, Lubetzki C.
    Prog Brain Res; 2009 Jun; 175():453-64. PubMed ID: 19660673
    [Abstract] [Full Text] [Related]

  • 17. Multiple Sclerosis: Basic and Clinical.
    Buzzard K, Chan WH, Kilpatrick T, Murray S.
    Adv Neurobiol; 2017 Jun; 15():211-252. PubMed ID: 28674983
    [Abstract] [Full Text] [Related]

  • 18. Activation of FXR by ganoderic acid A promotes remyelination in multiple sclerosis via anti-inflammation and regeneration mechanism.
    Jia Y, Zhang D, Li H, Luo S, Xiao Y, Han L, Zhou F, Wang C, Feng L, Wang G, Wu P, Xiao C, Yu H, Du J, Bao H.
    Biochem Pharmacol; 2021 Mar; 185():114422. PubMed ID: 33482151
    [Abstract] [Full Text] [Related]

  • 19. Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis.
    Rivera FJ, Aigner L.
    Biol Res; 2012 Mar; 45(3):257-68. PubMed ID: 23283435
    [Abstract] [Full Text] [Related]

  • 20. The complex world of oligodendroglial differentiation inhibitors.
    Kremer D, Aktas O, Hartung HP, Küry P.
    Ann Neurol; 2011 Apr; 69(4):602-18. PubMed ID: 21520230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.